GMEP 2025 Global Medical Equipment & Pharma Expo: Korea's Premier Medical Device Export Platform

The most powerful differentiator between GMEP and other medical device export consulting events is its complete physical and operational integration with KIMES. KIMES is Asia's largest medical device exhibition, held for five days each March at COEX in Seoul. With over 1,300 domestic and international companies operating booths across all of COEX's A, B, C, and D halls, and 77,000+ visitors in attendance, it is the preeminent annual event in the Asian medical device industry.

GMEP runs simultaneously within a dedicated area inside COEX during the KIMES period. The 140+ overseas buyers invited to GMEP's export consulting sessions conduct intensive 1:1 consultations during the day while freely touring the full KIMES exhibition to identify additional suppliers. The ability to visit the booths of 1,300+ companies directly opens numerous additional business opportunities beyond GMEP's official matching schedule. The structure allows buyers to capture two distinct value propositions in a single visit to Korea: GMEP's focused matching consultations and KIMES's comprehensive exhibition experience.

The synergy effect between KIMES and GMEP is quantifiable. According to KOTRA, 68% of GMEP-invited buyers identified additional suppliers during their KIMES exhibition visits, and 31% of these progressed to separate meetings with companies encountered at KIMES beyond the official GMEP schedule. In practical terms, GMEP buyers receive approximately 20 official 1:1 consultations through the matching program while gaining access to an average of 5–8 additional company contact opportunities through KIMES.

What fundamentally sets GMEP apart from private exhibition companies' commercial fairs is its public governance structure as a Ministry of Trade, Industry and Energy-hosted event. MOTIE operates GMEP as a core policy instrument for expanding Korean medical device exports, while KOTRA mobilizes its full network of 127 trade offices across 84 countries to manage buyer discovery, invitation, and post-event follow-up. This structure represents not merely administrative sponsorship but meaningful budget allocation and personnel deployment.

In particular, KOTRA's coverage of all overseas buyer airfare, accommodation, and interpretation costs is only possible because of this government support structure. The per-buyer support amount — including round-trip airfare from Dhaka to Seoul and a five-night Seoul business hotel stay — is estimated at approximately USD 2,500–4,000. Applied to 140+ invited buyers, KOTRA's buyer support budget for a single GMEP event alone reaches hundreds of millions of Korean won. This is a strategic national-level investment toward the policy objective of expanding Korean medical device exports.

GMEP 2025's full program is organized around three axes: 1:1 export consultations managed through KOTRA's precision pre-matching system; free-access KIMES exhibition visits; and factory tours of manufacturing facilities. This combination across a five-night, six-day schedule provides invited buyers with a complete platform for developing a three-dimensional understanding of Korea's medical device supply chain and selecting optimal partners.

Bangladesh is currently one of the fastest-growing medical device import markets in South Asia. A population of 170 million, rapid urbanization, expanding private healthcare services, and increased government investment in medical infrastructure are converging to drive annual medical device demand growth of 12–15%. In particular, demand for Korean products is growing distinctly in digital diagnostic imaging equipment, patient monitoring systems, IVD (in vitro diagnostics), and dental equipment.

The reasons Bangladeshi buyers select Korean medical devices are clear. Korean products combine quality and certifications comparable to European and American brands at prices 40–60% lower, with shorter delivery times and relatively accessible after-sales support due to geographic proximity. Korean companies' proactive market entry approach and localization commitment also function as trust signals. GMEP is the optimal interface where both parties' needs converge.

The KOTRA Dhaka Trade Office selected 33 companies as invited buyers for GMEP 2025, including Bangladeshi medical device distributors, hospital procurement teams, and government procurement agents. These 33 companies are verified buyers with confirmed purchase budgets and intent from across Bangladesh, with total potential purchase value estimated at over USD 42 million. Of the 33 invited buyers, 9 companies (27%) had no prior Korean medical device import experience — representing a prime opportunity for both parties to initiate new business relationships.

The USD 1.654M+ in consulting outcomes recorded at GMEP 2025 is more than a headline number. This is KOTRA's officially tabulated on-site contract figure — the aggregated total of contracts where Letters of Intent (LOIs) were signed or purchase orders exchanged between buyers and Korean companies during the two-day event. Given the nature of medical devices, on-site contracts tend to concentrate in consumables, IVD reagents, dental equipment, and small diagnostic devices where decision cycles are shorter — excluding high-value capital equipment (CT, MRI, etc.) where immediate contract execution is less practical.

The real measure of GMEP's impact, however, lies in the six-month post-event tracking figure. Even when contracts are not finalized on-site, KOTRA's post-event support drives additional contracts within six months of buyers returning home at a value 3.8 times the on-site figure. Applying this multiplier to the 2025 on-site figure of USD 1.654M, the estimated six-month post-event contract value is approximately USD 62.85 million. GMEP's total export contract generation from a single event therefore approaches USD 79 million or more.

GMEP 2025's successful staging and record-breaking contract outcomes are raising expectations for GMEP 2026. Since GMEP is a regular annual event held at COEX in conjunction with KIMES each March, Bangladeshi buyers wishing to participate in 2026 should begin preparation now. Invited buyer recruitment typically opens in October– November of the prior year through KOTRA's local trade offices.

Competition for selection as a GMEP invited buyer from Bangladesh is intensifying each year. Bangladesh's allocated position in 2025 was 33 companies, but interest from companies reportedly exceeded three times that figure. Early expression of intent (before October), detailed and specific procurement requirement documentation, and securing a recommendation letter from the Bangladesh Medical Device Association (BMDA) are the key factors elevating selection probability.

There is one thing Bangladeshi buyers must remember when applying for GMEP: the KOTRA Dhaka Trade Office monitors Bangladesh's medical device market year-round and supports matching between Bangladeshi buyers and Korean companies even outside GMEP season. Reaching out to the trade office for the first time to apply for GMEP can become the starting point of a long-term partnership with KOTRA. Regardless of GMEP selection outcomes, the trade office provides comprehensive advisory on Korean medical device imports at no cost.

GMEP 2025 once again demonstrated its standing as the platform in which MOTIE and KOTRA's years of accumulated medical device export support expertise is concentrated. USD 1.654M+ in on-site contracts, 4,000+ overseas buyers, 1,300+ participating companies, and 77,000+ visitors confirm that GMEP has established itself as Asia's representative medical device B2B trade platform. For medical device buyers from Bangladesh and other emerging markets, GMEP is the most efficient and cost-effective pathway to accessing Korea's advanced medical device supply chain. Preparation for the next GMEP begins with contacting the KOTRA Dhaka Trade Office today.